MeSH Browser

MeSH Heading: Postpoliomyelitis Syndrome
Tree Number(s): C01.207.618.750.750; C01.925.782.687.359.764.650; C05.651.534.750; C10.228.228.618.750.750; C10.228.854.525.850.750; C10.574.827; C10.586.750.850.750; C10.668.491.175.750; C10.668.864.500
Unique ID: D016262
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D016262
Scope Note: A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80)
Entry Version: POSTPOLIO SYNDROME
Entry Term(s): Muscular Atrophy, Postpoliomyelitis; Post-Polio Syndrome; Post-Poliomyelitis Muscular Atrophy; Post-Poliomyelitis Syndrome; Postpoliomyelitis Muscular Atrophy
NLM Classification #: WC 555
Previous Indexing: Poliomyelitis/complications (1983-1990)
See Also: Poliomyelitis
Public MeSH Note: 1991
History Note: 1991
Date Established: 1991/01/01
Date of Entry: 1999/11/08
Revision Date: 2021/06/30

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0024855
Scope Note: A syndrome characterized by new neuromuscular symptoms that occur at least 15 years after clinical stability has been attained in patients with a prior history of symptomatic poliomyelitis. Clinical features include new muscular weakness and atrophy of the limbs, bulbar innervated musculature, and muscles of respiration, combined with excessive fatigue, joint pain, and reduced stamina. The process is marked by slow progression and periods of stabilization. (From Ann NY Acad Sci 1995 May 25;753:68-80)
Terms: Postpoliomyelitis Syndrome Preferred Term
Term UI T048451
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1991); Muscular Atrophy, Postpoliomyelitis
Term UI T048449
Date04/27/1990
LexicalTag NON
ThesaurusID NLM (1991); Postpoliomyelitis Muscular Atrophy
Term UI T048450
Date03/29/1990
LexicalTag NON
ThesaurusID NLM (1991); Post-Poliomyelitis Muscular Atrophy
Term UI T048452
Date03/29/1990
LexicalTag NON
ThesaurusID NLM (1991); Post-Poliomyelitis Syndrome
Term UI T048453
Date03/28/1990
LexicalTag NON
ThesaurusID NLM (1991); Post-Polio Syndrome
Term UI T369253
Date11/08/1999
LexicalTag NON
ThesaurusID NLM (2000)

Postpoliomyelitis Syndrome MeSH Descriptor Data 2025